03.09.2015
- In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...
24.06.2015
- Pfizer has agreed to acquire the quadrivalent meningitis ACWY vaccines Nimenrix and Mencevax from GlaxoSmithKline (GSK) for €115 million. The deal, expected to close in the second...
20.04.2015
- French biopharmaceutical industry contract supplier Sartorius Stedim Biotech (SSM) has acquired BioSource, a privately owned Glasgow, Scotland-based biotech firm for an undisclosed...
31.03.2015
- Novartis is accelerating its efforts in the field of cancer immunotherapy with the launch of a dedicated research group and an alliance with US-based Aduro Biotech. The multi-year...
16.02.2015
- GlaxoSmithKline (GSK), the UK's largest drugmaker, has acquired Swiss-based GlycoVaxyn, a privately held specialist vaccine biopharmaceutical producer, from Edmond de Rothschild...
27.10.2014
- GlaxoSmithKline (GSK), the UK's largest pharmaceutical producer, said development of the company's experimental Ebola vaccine candidate is progressing "at an unprecedented rate,"...
15.10.2014
- Russian scientists are working on three potential Ebola vaccines and plan to introduce them within the next six months, health minister Veronika Skvortsova said, adding that one of...
29.08.2014
- An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...
